Up-regulation of Soluble Tumor Necrosis Factor Receptor Two in Plasma of HIV-Seropositive Individuals Who Use Opiates

Lisa A. Ryan, Michelle Brester, Daryl Bohac, Susan Morgello, Jialin C Zheng

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Previously, we reported an increase in soluble tumor necrosis factor-alpha receptor two (sTNF-R2) and soluble CD14 (sCD14) in the plasma of HFV-seropositive individuals with neurocognitive dysfunction compared to their cognitively intact counterparts. As intravenous drug use is not only a risk factor for HFV but also an immunomodulator, we sought to examine the effects of drug use on soluble markers of immune activation. These relationships were investigated in 25 patients with late stage HIV-1 disease. TNF-α, sTNF-R1, sTNF-R2, and sCD14 were measured in patient plasma. These values were correlated with drug use and neurocognitive function. sTNF-R2 was significantly up-regulated in those patients who used opiates compared to those who did not. There was no difference in TNF-α, sTNF-R1, or sCD14 between the groups. Further, there was no connection between opiate use and neurocognitive dysfunction.

Original languageEnglish (US)
Pages (from-to)41-45
Number of pages5
JournalAIDS Research and Human Retroviruses
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Opiate Alkaloids
Tumor Necrosis Factor Receptors
Up-Regulation
HIV
Pharmaceutical Preparations
Immunologic Factors
HIV-1
Tumor Necrosis Factor-alpha
Biomarkers

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Up-regulation of Soluble Tumor Necrosis Factor Receptor Two in Plasma of HIV-Seropositive Individuals Who Use Opiates. / Ryan, Lisa A.; Brester, Michelle; Bohac, Daryl; Morgello, Susan; Zheng, Jialin C.

In: AIDS Research and Human Retroviruses, Vol. 20, No. 1, 01.01.2004, p. 41-45.

Research output: Contribution to journalArticle

@article{1ea0b195acfa44daa736a659e339960f,
title = "Up-regulation of Soluble Tumor Necrosis Factor Receptor Two in Plasma of HIV-Seropositive Individuals Who Use Opiates",
abstract = "Previously, we reported an increase in soluble tumor necrosis factor-alpha receptor two (sTNF-R2) and soluble CD14 (sCD14) in the plasma of HFV-seropositive individuals with neurocognitive dysfunction compared to their cognitively intact counterparts. As intravenous drug use is not only a risk factor for HFV but also an immunomodulator, we sought to examine the effects of drug use on soluble markers of immune activation. These relationships were investigated in 25 patients with late stage HIV-1 disease. TNF-α, sTNF-R1, sTNF-R2, and sCD14 were measured in patient plasma. These values were correlated with drug use and neurocognitive function. sTNF-R2 was significantly up-regulated in those patients who used opiates compared to those who did not. There was no difference in TNF-α, sTNF-R1, or sCD14 between the groups. Further, there was no connection between opiate use and neurocognitive dysfunction.",
author = "Ryan, {Lisa A.} and Michelle Brester and Daryl Bohac and Susan Morgello and Zheng, {Jialin C}",
year = "2004",
month = "1",
day = "1",
doi = "10.1089/088922204322749486",
language = "English (US)",
volume = "20",
pages = "41--45",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Up-regulation of Soluble Tumor Necrosis Factor Receptor Two in Plasma of HIV-Seropositive Individuals Who Use Opiates

AU - Ryan, Lisa A.

AU - Brester, Michelle

AU - Bohac, Daryl

AU - Morgello, Susan

AU - Zheng, Jialin C

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Previously, we reported an increase in soluble tumor necrosis factor-alpha receptor two (sTNF-R2) and soluble CD14 (sCD14) in the plasma of HFV-seropositive individuals with neurocognitive dysfunction compared to their cognitively intact counterparts. As intravenous drug use is not only a risk factor for HFV but also an immunomodulator, we sought to examine the effects of drug use on soluble markers of immune activation. These relationships were investigated in 25 patients with late stage HIV-1 disease. TNF-α, sTNF-R1, sTNF-R2, and sCD14 were measured in patient plasma. These values were correlated with drug use and neurocognitive function. sTNF-R2 was significantly up-regulated in those patients who used opiates compared to those who did not. There was no difference in TNF-α, sTNF-R1, or sCD14 between the groups. Further, there was no connection between opiate use and neurocognitive dysfunction.

AB - Previously, we reported an increase in soluble tumor necrosis factor-alpha receptor two (sTNF-R2) and soluble CD14 (sCD14) in the plasma of HFV-seropositive individuals with neurocognitive dysfunction compared to their cognitively intact counterparts. As intravenous drug use is not only a risk factor for HFV but also an immunomodulator, we sought to examine the effects of drug use on soluble markers of immune activation. These relationships were investigated in 25 patients with late stage HIV-1 disease. TNF-α, sTNF-R1, sTNF-R2, and sCD14 were measured in patient plasma. These values were correlated with drug use and neurocognitive function. sTNF-R2 was significantly up-regulated in those patients who used opiates compared to those who did not. There was no difference in TNF-α, sTNF-R1, or sCD14 between the groups. Further, there was no connection between opiate use and neurocognitive dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=0742307441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0742307441&partnerID=8YFLogxK

U2 - 10.1089/088922204322749486

DO - 10.1089/088922204322749486

M3 - Article

VL - 20

SP - 41

EP - 45

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 1

ER -